Acadia Pharmaceuticals reported $88.22M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cara Therapeutics CARA:US $ 15.53M 358K
Corcept Therapeutics CORT:US $ 44.76M 0.64M
Cytokinetics CYTK:US $ 80.87M 19.1M
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
Marinus Pharmaceuticals MRNS:US $ 37.68M 20.98M
Moderna Inc MRNA:US 9.96B 1.12B
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Prothena PRTA:US 29.2M 23.7M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vanda Pharmaceuticals VNDA:US $ 72M 0.01M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M
Zogenix ZGNX:US $ 78.43M 9.09M